MARIETTA, Ga. - April 22, 2020 - (Newswire.com)
HTL-STREFA, the world-wide leader and inventor of the first safety lancet, announced today that they are making available their proprietary best practice for proper lancing technique to all front-line caregivers combating COVID-19. HTL-STREFA's intent is to ensure all caregivers providing finger-stick (capillary blood) testing for COVID-19 antibodies understand how best to perform the procedure to ensure high-quality samples while minimizing patient pain and discomfort. To support education of the technique, HTL-STREFA is making available an illustrated step-by-step copyrighted poster outlining their lancing technique.
"In our experience, we have seen caregivers use varying methods in lancing with their patients,” said Michael Billedo, Safety Marketing Director for HTL-STREFA, Inc. “We thought there would be strong interest amongst caregivers if we consolidated these best practices from their peers into a simple step-by-step process. We then consulted with the Center for Phlebotomy Education (www.phlebotomy.com) to validate that these instructions are safe and effective,” Mr. Billedo continues. “For example, we were intrigued to learn specific fingers and locations are preferred for sampling. Also, we were further surprised to learn that squeezing or ‘milking’ the location after pricking is not encouraged as it risks introducing fluid that could compromise the sample quality and results.”
Having invented the safety lancet in 1994, HTL-STREFA has become a global reference and preferred partner for capillary blood sampling and safety medical sharps. The company’s safety lancets are designed and proven to obtain various blood volumes measured in microliters (µL) for various assays, inclusive of COVID-19, and are available for immediate delivery.
If you are a caregiver and want to obtain the process/poster free of charge, please contact Michael Billedo: michael.billedo@htl-strefa.com.
For more information on ordering HTL-STREFA products, please contact Customer Service: customerservice@htl-strefa.com or 770-528-0410.
HTL-STREFA (www.htl-strefa.com) is a leading medical device company with over 30 years of experience, belonging to MTD Group (www.mtdglobal.com). The company is a leading global manufacturer of proprietary capillary blood sampling and drug delivery devices with core expertise in diabetes and safety sharps. MTD solutions, made with cutting-edge technologies in its production plants in Europe, are designed to improve the safety, quality, and comfort of use of medical devices for both patients and healthcare providers, and are distributed in over 100 countries worldwide.
Media Contact:
Jessica Forrest
Phone: 678-265-4319
Email: jessica.forrest@htl-strefa.com
Press Release Service by Newswire.com
Original Source: HTL-STREFA, Inc. Provides Best Practice Lancing Technique to Aid in COVID-19 Antibody Testing
